Seeking Alpha

Endo Pharmaceuticals (ENDP +1.5%) gains after receiving FDA approval for its Felodipine...

Endo Pharmaceuticals (ENDP +1.5%) gains after receiving FDA approval for its Felodipine extended-release tablets, a generic version of AstraZeneca's (AZN +0.3%) Plendil blood pressure medication.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs